Yorozuya, T., Nagano, Y., Chiba, H., Imai, Y., Yasuda, K., Sudo, Y., . . . Shioya, M. (2021). Repeated treatment with gefitinib and alectinib in a patient with multiple EGFR-mutant and ALK-mutant lung adenocarcinomas: A case report. Respir Med Case Rep.

Yorozuya, Takafumi, Yutaro Nagano, Hirofumi Chiba, Yui Imai, Kento Yasuda, Yuta Sudo, Tetsuya Taya, and Makoto Shioya. "Repeated Treatment With Gefitinib and Alectinib in a Patient With Multiple EGFR-mutant and ALK-mutant Lung Adenocarcinomas: A Case Report." Respir Med Case Rep 2021.

Yorozuya, Takafumi, et al. "Repeated Treatment With Gefitinib and Alectinib in a Patient With Multiple EGFR-mutant and ALK-mutant Lung Adenocarcinomas: A Case Report." Respir Med Case Rep 2021.